Search results

Filters
Close
ADDED DATE
Added date
AUTHOR Please select
TOPICS Please select
WATCH / LISTEN / READ TIME
Essentials in the Post-operative Evaluation of Congenital Heart Disease
Author(s): Jonathan N Johnson , Frank Cetta Added: 3 years ago
The last 60 years have seen significant changes in the care of congenital heart disease for both pediatric and adult patients. Increasing patient survival rates have widened the number and scope of potential patients seen by congenital cardiologists.1 These patients often undergo multiple surgeries, particularly since few lesions are truly ‘repaired.’ The majority of patients will have residua or… View more

Vascular Disease and Surgery

Electrophysiology & Arrhythmia
AHA 22: NOVA: Botulinium Toxin Type A in Patients with Post-Operative Atrial Fibrillation
Author(s): Jonathan Piccini Added: 1 year ago
AHA 22 - Dr Jonathan Piccini(Duke University Medical Center, Durham, US) joins us to discuss the findings of the NOVA Phase II trial (NCT03779841). NOVA Phase II is a multicenter, randomized, dose-ranging study that aims to find the efficacy and safety of botulinum toxin type A (AGN-151607) (AbbVie)in preventing post-operative atrial fibrillation (POAF) in patients undergoing open-chest cardiac… View more

Vascular Disease and Surgery

Electrophysiology & Arrhythmia
AHA 21: AXIOMATIC-TKR: Patients Treated with Milvexian Show Reduced Rate of Venous Thromboembolism
Author(s): Jeffrey Weitz Added: 2 years ago
Dr Jeffrey Weitz (Thrombosis & Atherosclerosis Research Institute, Ontario, CA) presents the results of the Axiomatic-TKR Study, a phase II dose-ranging study that aims to examine the effect of Milvexian versus Enoxaparin in the treatment of venous thromboembolism in patients undergoing total-knee replacement surgery.The study met its efficacy criteria, where the rate of thromboembolism was… View more

Vascular Disease and Surgery
Author(s): Zvonimir Krajcer Added: 3 years ago
Annually, in the US approximately 15,000 deaths are caused by a rupture of an abdominal aortic aneurysm (AAA), making it the 13th leading cause of death. AAA is often referred to as ‘the silent killer’ and is estimated to affect 2.7 million Americans, half of whom are not correctly diagnosed.1 If left untreated, the risk of rupture is 80–90% through progressive thinning of the aortic vessel,… View more

Prevention & Chronic Conditions
Author(s): Stuart W Jamieson Added: 3 years ago
Pulmonary endarterectomy for the treatment of pulmonary hypertension from chronic thromboembolic disease is an uncommonly employed surgical procedure. However, this operation provides immediate and permanent relief of the pulmonary hypertension associated with the sequelae of unresolved pulmonary thromboembolic disease. Patients are generally not referred for operation because of a lack of… View more

Prevention & Chronic Conditions
Biljana Parapid
Job title: Assistant Professor of Cardiology
Personal History Dr Biljana Parapid was raised in a family dedicated to research and medicine. A Cardiologist trained in Serbia, the United States and France, she now practices in her hometown of Belgrade, Serbia.2 Dr Parapid is focused on women's health with a special passion for CardioObstetrics. Her clinical work is in primary and secondary prevention of coronary artery disease in women… View more
AHA Scientific Sessions 2022 Late-Breaking Science Coverage
Author(s): Joseph A Hill , Mirvat Alasnag Added: 1 year ago
Stay updated with the latest data in cardiovascular science with the help of recognised experts and new voices offering practical summaries, in-depth discussions and critical reviews. With their fingers on the pulse of cardiovascular innovation, Prof Van Mieghem and Dr Daemen offer their succinct and insightful take on the most expected trials of AHA 22 in their regular review series View… View more

Standards & Guidelines

Heart Failure
Author(s): Michael F Morris , Philip A Araoz Added: 3 years ago
Mitral valve dysfunction is the most common cause of valvular disease in the US.1 Although echocardiography is the primary non-invasive modality for visualizing the mitral valve, advances in technology continue to allow for improved evaluation of mitral disease with magnetic resonance imaging (MRI) and computed tomography (CT).2,3 Currently, the role for MRI and CT assessment of the mitral valve… View more

Vascular Disease and Surgery

Imaging & Diagnostics
Author(s): Christopher J White Added: 3 years ago
More than three-quarters of a million Americans will suffer a stroke this year. Stroke ranks as the third most common cause of death after heart disease and cancer. It is the number one cause of disability among adults and the main reason for rehabilitation. Many, but not all, strokes are related to atherosclerosisÔÇöthe same disease that causes heart attacks. Blockage of one of the two main… View more

Prevention & Chronic Conditions

Intervention
Author(s): William T Brinkman , Wilson Y Szeto , Joseph E Bavaria Added: 3 years ago
The introduction of endovascular stent graft technology has ushered in a new era in therapy for diseases of the descending thoracic aorta. This ‘radical and revolutionary’ stent graft technology has been accompanied by simultaneous advances in non-invasive imaging and materials technology. The technical challenges of stent graft deployment in the descending thoracic aorta—such as proximity to the… View more

Intervention